Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1986 Nov;83(21):8162–8166. doi: 10.1073/pnas.83.21.8162

Purification and partial characterization of prostate-derived growth factor.

S Maehama, D Li, H Nanri, J F Leykam, T F Deuel
PMCID: PMC386887  PMID: 2430278

Abstract

A potent growth-promoting polypeptide, the prostate-derived growth factor (PrDGF), has been purified to apparent homogeneity from acid extracts of rat prostatic tissue using ion-exchange, reverse-phase, and gel-permeation chromatography. PrDGF migrates as a single protein-staining band in NaDodSO4/PAGE in precise correspondence to extractable PrDGF activity in nonstained NaDodSO4 gels. PrDGF is acid- and heat-stable but is sensitive to reduction or protease treatment. PrDGF is an acidic (pI 5.0) protein of approximately equal to 25 kDa in NaDodSO4/polyacrylamide gels and of approximately equal to 6-8 kDa in reduced NaDodSO4/polyacrylamide gels. PrDGF stimulates the linear incorporation of [methyl-3H]thymidine into normal rat kidney cells between 0 and 16 ng/ml. PrDGF appears to differ from other known growth factors in chemical composition and biological properties, suggesting that PrDGF is a previously undescribed growth factor.

Full text

PDF
8162

Images in this article

8163Image
on p.8163
8163Image
on p.8163
8163Image
on p.8163
8164Image
on p.8164

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Antoniades H. N., Scher C. D., Stiles C. D. Purification of human platelet-derived growth factor. Proc Natl Acad Sci U S A. 1979 Apr;76(4):1809–1813. doi: 10.1073/pnas.76.4.1809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bano M., Salomon D. S., Kidwell W. R. Purification of a mammary-derived growth factor from human milk and human mammary tumors. J Biol Chem. 1985 May 10;260(9):5745–5752. [PubMed] [Google Scholar]
  3. Bartsch G., Müller H. R., Oberholzer M., Rohr H. P. Light microscopic stereological analysis of the normal human prostate and of benign prostatic hyperplasia. J Urol. 1979 Oct;122(4):487–491. doi: 10.1016/s0022-5347(17)56476-9. [DOI] [PubMed] [Google Scholar]
  4. COHEN S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J Biol Chem. 1962 May;237:1555–1562. [PubMed] [Google Scholar]
  5. Carpenter G., Cohen S. Epidermal growth factor. Annu Rev Biochem. 1979;48:193–216. doi: 10.1146/annurev.bi.48.070179.001205. [DOI] [PubMed] [Google Scholar]
  6. Cook G. B., Watson F. R. Events in the natural history of prostate cancer: using salvage curves, mean age distributions and contingency coefficients. J Urol. 1968 Jan;99(1):87–96. doi: 10.1016/S0022-5347(17)62647-8. [DOI] [PubMed] [Google Scholar]
  7. Cooper J. A., Bowen-Pope D. F., Raines E., Ross R., Hunter T. Similar effects of platelet-derived growth factor and epidermal growth factor on the phosphorylation of tyrosine in cellular proteins. Cell. 1982 Nov;31(1):263–273. doi: 10.1016/0092-8674(82)90426-3. [DOI] [PubMed] [Google Scholar]
  8. Deuel T. F., Huang J. S. Platelet-derived growth factor. Structure, function, and roles in normal and transformed cells. J Clin Invest. 1984 Sep;74(3):669–676. doi: 10.1172/JCI111482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Deuel T. F., Huang J. S., Proffitt R. T., Baenziger J. U., Chang D., Kennedy B. B. Human platelet-derived growth factor. Purification and resolution into two active protein fractions. J Biol Chem. 1981 Sep 10;256(17):8896–8899. [PubMed] [Google Scholar]
  10. FRANKS L. M. Benign nodular hyperplasia of the prostate; a review. Ann R Coll Surg Engl. 1953 Feb;14(2):92–106. [PMC free article] [PubMed] [Google Scholar]
  11. Galasko C. S. The pathological basis for skeletal scintigraphy. J Bone Joint Surg Br. 1975 Aug;57(3):353–359. [PubMed] [Google Scholar]
  12. Gospodarowicz D., Bialecki H., Greenburg G. Purification of the fibroblast growth factor activity from bovine brain. J Biol Chem. 1978 May 25;253(10):3736–3743. [PubMed] [Google Scholar]
  13. Gospodarowicz D. Purification of a fibroblast growth factor from bovine pituitary. J Biol Chem. 1975 Apr 10;250(7):2515–2520. [PubMed] [Google Scholar]
  14. Harper G. P., Barde Y. A., Burnstock G., Carstairs J. R., Dennison M. E., Suda K., Vernon C. A. Guinea pig prostate is a rich source of nerve growth factor. Nature. 1979 May 10;279(5709):160–162. doi: 10.1038/279160a0. [DOI] [PubMed] [Google Scholar]
  15. Harper G. P., Glanville R. W., Thoenen H. The purification of nerve growth factor from bovine seminal plasma. Biochemical characterization and partial amino acid sequence. J Biol Chem. 1982 Jul 25;257(14):8541–8548. [PubMed] [Google Scholar]
  16. Harper G. P., Thoenen H. The distribution of nerve growth factor in the male sex organs of mammals. J Neurochem. 1980 Apr;34(4):893–903. doi: 10.1111/j.1471-4159.1980.tb09663.x. [DOI] [PubMed] [Google Scholar]
  17. Ikeda T., Sirbasku D. A. Purification and properties of a mammary-uterine-pituitary tumor cell growth factor from pregnant sheep uterus. J Biol Chem. 1984 Apr 10;259(7):4049–4064. [PubMed] [Google Scholar]
  18. Ishida Y., Fujita T., Asai K. New detection and separation method for amino acids by high-performance liquid chromatography. J Chromatogr. 1981 Jan 16;204:143–148. doi: 10.1016/s0021-9673(00)81650-7. [DOI] [PubMed] [Google Scholar]
  19. Jacobs S. C., Lawson R. K. Mitogenic factor in human prostate extracts. Urology. 1980 Nov;16(5):488–491. doi: 10.1016/0090-4295(80)90602-0. [DOI] [PubMed] [Google Scholar]
  20. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  21. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  22. Maciag T., Cerundolo J., Ilsley S., Kelley P. R., Forand R. An endothelial cell growth factor from bovine hypothalamus: identification and partial characterization. Proc Natl Acad Sci U S A. 1979 Nov;76(11):5674–5678. doi: 10.1073/pnas.76.11.5674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Maciag T., Hoover G. A., Weinstein R. High and low molecular weight forms of endothelial cell growth factor. J Biol Chem. 1982 May 25;257(10):5333–5336. [PubMed] [Google Scholar]
  24. Pradhan B. K., Chandra K. Morphogenesis of nodular hyperplasia--prostate. J Urol. 1975 Feb;113(2):210–213. doi: 10.1016/s0022-5347(17)59446-x. [DOI] [PubMed] [Google Scholar]
  25. Rinderknecht E., Humbel R. E. Polypeptides with nonsuppressible insulin-like and cell-growth promoting activities in human serum: isolation, chemical characterization, and some biological properties of forms I and II. Proc Natl Acad Sci U S A. 1976 Jul;73(7):2365–2369. doi: 10.1073/pnas.73.7.2365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Roberts A. B., Anzano M. A., Meyers C. A., Wideman J., Blacher R., Pan Y. C., Stein S., Lehrman S. R., Smith J. M., Lamb L. C. Purification and properties of a type beta transforming growth factor from bovine kidney. Biochemistry. 1983 Dec 6;22(25):5692–5698. doi: 10.1021/bi00294a002. [DOI] [PubMed] [Google Scholar]
  27. Ross R., Glomset J. A. The pathogenesis of atherosclerosis (first of two parts). N Engl J Med. 1976 Aug 12;295(7):369–377. doi: 10.1056/NEJM197608122950707. [DOI] [PubMed] [Google Scholar]
  28. Ross R. The pathogenesis of atherosclerosis. Mech Ageing Dev. 1979 Mar;9(5-6):435–440. doi: 10.1016/0047-6374(79)90084-8. [DOI] [PubMed] [Google Scholar]
  29. Savage C. R., Jr, Cohen S. Epidermal growth factor and a new derivative. Rapid isolation procedures and biological and chemical characterization. J Biol Chem. 1972 Dec 10;247(23):7609–7611. [PubMed] [Google Scholar]
  30. Savage C. R., Jr, Inagami T., Cohen S. The primary structure of epidermal growth factor. J Biol Chem. 1972 Dec 10;247(23):7612–7621. [PubMed] [Google Scholar]
  31. Server A. C., Shooter E. M. Nerve growth factor. Adv Protein Chem. 1977;31:339–409. doi: 10.1016/s0065-3233(08)60221-1. [DOI] [PubMed] [Google Scholar]
  32. Simpson E., Harrod J., Eilon G., Jacobs J. W., Mundy G. R. Identification of a messenger ribonucleic acid fraction in human prostatic cancer cells coding for a novel osteoblast-stimulating factor. Endocrinology. 1985 Oct;117(4):1615–1620. doi: 10.1210/endo-117-4-1615. [DOI] [PubMed] [Google Scholar]
  33. Story M. T., Jacobs S. C., Lawson R. K. Epidermal growth factor is not the major growth-promoting agent in extracts of prostatic tissue. J Urol. 1983 Jul;130(1):175–179. doi: 10.1016/s0022-5347(17)51018-6. [DOI] [PubMed] [Google Scholar]
  34. Thomas K. A., Rios-Candelore M., Fitzpatrick S. Purification and characterization of acidic fibroblast growth factor from bovine brain. Proc Natl Acad Sci U S A. 1984 Jan;81(2):357–361. doi: 10.1073/pnas.81.2.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Todaro G. J., De Larco J. E., Fryling C., Johnson P. A., Sporn M. B. Transforming growth factors (TGFs): properties and possible mechanisms of action. J Supramol Struct Cell Biochem. 1981;15(3):287–301. doi: 10.1002/jsscb.1981.380150306. [DOI] [PubMed] [Google Scholar]
  36. Vogel A., Raines E., Kariya B., Rivest M. J., Ross R. Coordinate control of 3T3 cell proliferation by platelet-derived growth factor and plasma components. Proc Natl Acad Sci U S A. 1978 Jun;75(6):2810–2814. doi: 10.1073/pnas.75.6.2810. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES